Get started
Author

JAMES TARTAGLIA

Observed names: J Tartaglia, J. Tartaglia, James Tartaglia
ORCID: 0000-0002-3399-1926
Observed ORCID: 0000-0002-3399-1926
OpenAlex ID: A5110053280
ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency
2002 · R. Pal, D. Venzon, et al. · Journal of Virology · 230
Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Cytolytic T Lymphocyte Responses in Seronegative Adults by a Nonreplicating, Host-Range-Restricted Canarypox Vector (ALVAC) Carrying the HIV-1MN env Gene
1995 · M. A. Egan, W. A. Pavlat, et al. · The Journal of Infectious Diseases · 100
Recombinant viruses as a tool for therapeutic vaccination against human cancers
2000 · M.C Bonnet, J Tartaglia, et al. · Immunology Letters · 95
Induction of Cytotoxic T Lymphocytes by Recombinant Canarypox (ALVAC) and Attenuated Vaccinia (NYVAC) Viruses Expressing the HIV-1 Envelope Glycoprotein
1993 · William I. Cox, James Tartaglia, et al. · Virology · 94
Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2)
2003 · T-M Jourdier, C Moste, et al. · Gene Therapy · 79
Highly Attenuated HTLV Type I env Poxvirus Vaccines Induce Protection against a Cell-Associated HTLV Type I Challenge in Rabbits
1995 · GENOVEFFA FRANCHINI, JAMES TARTAGLIA, et al. · AIDS Research and Human Retroviruses · 52
Role of the Vaccinia Virus E3L and K3L Gene Products in Rescue of VSV and EMCV from the Effects of IFN-α
1998 · SCOTT T. SHORS, ELIZABETH BEATTIE, et al. · Journal of Interferon & Cytokine Research · 48
Multiple Immunizations with Attenuated Poxvirus HIV Type 2 Recombinants and Subunit Boosts Required for Protection of Rhesus Macaques
1996 · MARIA MYAGKIKH, SHABNAM ALIPANAH, et al. · AIDS Research and Human Retroviruses · 48
Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
1995 · E Paoletti, J Taylor, et al. · PubMed · 40
The mode of presentation and route of administration are critical for the induction of immune responses to p53 and antitumor immunity
1998 · Christian Hurpin, Chantal Rotarioa, et al. · Vaccine · 33
Applications of canarypox (ALVAC) vectors in human and veterinary vaccination.
1994 · J Taylor, J Tartaglia, et al. · PubMed · 32
Use of predictive markers of HIV disease progression in vaccine trials
2009 · S. Gurunathan, R. El Habib, et al. · Vaccine · 27
Novel poxvirus strains as research tools and vaccine vectors
1993 · J. Tartaglia, J. Taylor, et al. · 17
Live Attenuated Vaccinia and Other Poxviruses as Delivery Systems: Public Health Issues
1995 · MARION E. PERKUS, JILL TAYLOR, et al. · Annals of the New York Academy of Sciences · 16
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector
2019 · M. Giel-Moloney, M. Esteban, et al. · Scientific Reports · 11
PDF
Modulation of the antibody response to the HIV envelope subunit by co-administration of infectious or heat-inactivated canarypoxvirus (ALVAC) preparations
2001 · F Boudet, M Chevalier, et al. · Vaccine · 10
Design and In Vivo Immunogenicity of a Polyvalent Vaccine Based on SIVmac Regulatory Genes
2002 · Z. Hel, E. Tryniszewska, et al. · DNA and Cell Biology · 9
Specific Activation Strategies for Amplification of Low CTL Signals
1992 · Kent J. Weinhold, J. Tartaglia, et al. · AIDS Research and Human Retroviruses · 5
Live recombinant viral vaccines.
1990 · J. Tartaglia, Enzo Paoletti · 5
Elucidating the structure and function of double-stranded RNA genetic elements associated with biological control of chestnut blight.
1989 · Bradley I. Hillman, Rae B, et al. · Europe PMC (PubMed Central) · 5
Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial
2012 · G Franchini, P Pegu, et al. · Retrovirology · 2
PDF
OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial
2009 · MS de Souza, R Trichavaroj, et al. · Retrovirology · 2
PDF
OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines
2009 · B Jacobs, K Kibler, et al. · Retrovirology · 1
PDF
Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses
2012 · SL Hulot, BT Korber, et al. · Retrovirology
PDF
Immunogenicity and protective efficacy of HTLV-I env and env+gag NYVAC vaccine in Squirrel Monkey (Saïmiri sciureus)
1999 · M. Kazanji, J. Tartaglia, et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
Works count: 26
Citation count: 961
H-index: 14
I10-index: 16
Year
Topic
Type